We’re often fortunate enough to hear about a new biotech company before the rest of the world does, and sometimes even before the startup founders have chosen a name. But it’s never too early to start the conversation around IT infrastructure and cyber security – both essential foundations for long-term success.
Over the past 12 years, we’ve taken great pride in supporting the launch and scale-up of early-stage companies across the life sciences sector. From the very beginning of the startup journey, we’ve worked closely with founders and their teams to implement scalable, secure systems designed to keep pace with rapid growth and evolving business needs.
We’ve seen firsthand the milestones that mark a successful startup: from securing early angel investors to achieving breakthroughs in clinical trials, winning prestigious awards, and ultimately making a real impact on patients’ lives. Some of the companies we’ve supported have opened offices across multiple countries and continents; others have gone public, while several have achieved a successful exit strategy through acquisition by major pharmaceutical companies.
For the last three years, we’ve also proudly partnered with the Accelerate @ Babraham programme – offering tailored IT and cyber security advice to innovative, early-stage startups. Combined with our long-standing experience in the biotech and life science space, this has given us deep insight into the unique challenges faced during every stage of the startup journey, and how best to navigate them.
Common challenges
Understanding the growth plan from the outset, and aligning a proactive IT strategy with the overall business plan is essential for long-term success, particularly in the fast-paced world of tech startups and small businesses.
Many founders, especially in early-stage companies, adopt platforms that are quick and inexpensive to set up. While these choices may work initially, they often lack the scalability, security, and functionality required to support rapid growth, leading to expensive and disruptive migration projects later. It’s a familiar story – one of the key reasons a startup fails to maintain momentum.
By planning ahead and making informed, strategic technology decisions, startups can lay a solid IT foundation that attracts seed funding, supports prototype development, enables strategic partnerships, and resonates with the target audience – all while building resilience for the future. Specialised IT Support for Pharma and Biotech can play a crucial role in this process, ensuring that systems are secure, scalable, and aligned with industry-specific needs.
Additional IT pitfalls and oversights
- Security: Failing to apply an appropriate security baseline from day one can expose the business to unnecessary risk and incur increased costs when standards need to be raised later, particularly under the scrutiny of investor or private equity due diligence.
- IT Culture: A relaxed, informal approach to data access and sharing can become embedded in company culture, making it difficult to change behaviours as the organisation matures.
- Onboarding Experience: Overlooking the IT setup for new staff can lead to poor first impressions and productivity delays, especially in a competitive job market where retaining top talent is vital.
- End-User Devices: Using consumer-grade devices without encryption, proper licensing, or vendor support can compromise security and reliability.
- Physical Infrastructure: Making short-term decisions on office or lab infrastructure can lead to costly upgrades well before the original investments reach end-of-life.
- Labs (Equipment): Deploying computers and software in laboratory environments without IT involvement can introduce vulnerabilities and compatibility issues.
- Labs (Data): Critical lab-generated data is sometimes not treated with the appropriate level of backup and resilience, putting valuable research at risk.
- Choosing Partners: Collaborators, suppliers, and external partners should all meet appropriate security and compliance standards. A weak link in your ecosystem can affect the entire business.
- Data Science Teams: Often, data scientists set up their own environments independently, which may lead to inconsistencies in security and governance – particularly critical for businesses handling sensitive data.
- Governance & Compliance: Lack of focus on IT governance and security protocols becomes a significant risk when preparing for funding rounds or exit events, particularly as angel investors and VCs increase their scrutiny.
IT foundation points for emerging Life Science companies
It’s much easier (and more cost-effective) to get things right from the start.
For early stage startups in the life sciences sector, building a strong IT foundation is crucial. Given the data-intensive nature of biotech, alongside stringent security, compliance, and collaboration needs, robust IT systems are essential for scalable growth.
Key considerations across startup stages include:
Laying the right groundwork: setting up domain names, email services, secure data storage, end-user devices, reliable backups, and vendor selection criteria.
Understanding the importance of data management and governance from day one.
Identifying cyber security risks that could affect intellectual property, financial stability, reputation, and project timelines – and adopting simple best practices to mitigate them.
Leveraging market research and artificial intelligence tools to inform decisions and drive innovation.
Most startup founders don’t have the time or in-house expertise to address these areas alone – that’s where we can help.
How we can help at a strategic level
Conduct a strategic IT audit to identify gaps, provide clear recommendations, and develop a tailored roadmap for growth.
Organise a roundtable session with leadership teams, including startup founders and senior executives – to raise awareness of cyber security threats and strengthen organisational resilience.
Offer guidance or deliver tailored sessions to individuals, successful startups, or growing companies, providing strategic IT insight as they scale.
Act as a consultative partner, available to advise on key IT decisions, major projects, or when engaging with private equity firms seeking operational due diligence or strategic alignment.
At Zenzero, our dedicated life science team brings over a decade of experience supporting companies across all stages of growth, from early startup success to established industry leaders. We’ve worked closely with organisations navigating venture capital, meeting market demand, and scaling into successful businesses.
If you’re looking for a partner who understands the unique challenges and opportunities in life sciences, we’re perfectly placed to have a conversation about how we can support your journey. Get in touch today!